SNN - Smith & Nephew plc

NYSE - NYSE Delayed Price. Currency in USD
34.78
-0.38 (-1.08%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close35.16
Open34.57
Bid0.00 x 0
Ask0.00 x 0
Day's Range34.45 - 34.83
52 Week Range29.51 - 40.43
Volume942,202
Avg. Volume626,498
Market Cap14.48B
Beta0.44
PE Ratio (TTM)17.71
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.62 (1.75%)
Ex-Dividend Date2017-10-05
1y Target EstN/A
Trade prices are not sourced from all markets
  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Video2 months ago

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."

  • Is There Now An Opportunity In Smith & Nephew plc (LON:SN.)?
    Simply Wall St.2 days ago

    Is There Now An Opportunity In Smith & Nephew plc (LON:SN.)?

    Let’s talk about the popular Smith & Nephew plc (LSE:SN.). The company’s shares saw significant share price volatility over the past couple of months on the LSE, rising to theRead More...

  • Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm
    Zacks5 days ago

    Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

    Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.

  • Want To Invest In Smith & Nephew plc (LSE:SN)? Here’s How It Performed Lately
    Simply Wall St.17 days ago

    Want To Invest In Smith & Nephew plc (LSE:SN)? Here’s How It Performed Lately

    Assessing Smith & Nephew plc’s (LSE:SN.) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense checkRead More...

  • Will a 'Huge Tax Cut' Ease Burden for MedTech Players?
    Zacks24 days ago

    Will a 'Huge Tax Cut' Ease Burden for MedTech Players?

    How is the MedTech industry placed in the wake of the current political conundrum surrounding tax reforms?

  • Stocks Generating Improved Relative Strength: Smith & Nephew
    Investor's Business Dailylast month

    Stocks Generating Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Smith & Nephew Shows Rising Relative Price Performance; Still Shy Of Key Threshold
    Investor's Business Dailylast month

    Smith & Nephew Shows Rising Relative Price Performance; Still Shy Of Key Threshold

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Reuterslast month

    Under pressure Smith & Nephew to focus on efficiency

    Smith & Nephew (SN.L) said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott. Two reports last month said that Paul Singer's U.S. hedge fund had taken a stake in Smith & Nephew, reigniting perennial speculation that it could be acquired by a U.S. rival such as Stryker (SYK.N) or be broken up.

  • Reuterslast month

    Under pressure Smith & Nephew to focus on efficiency

    Smith & Nephew said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott. Two reports last month said that Paul Singer's U.S. hedge fund had taken a stake in Smith & Nephew, reigniting perennial speculation that it could be acquired by a U.S. rival such as Stryker or be broken up.

  • Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew
    Zacks2 months ago

    Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew

    Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew

  • Reuters2 months ago

    Smith & Nephew to buy Rotation Medical for up to $210 million

    Medical technology group Smith & Nephew (SN.L), which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million (£159 million). The British company, best known for its replacement hips and knees, will pay an initial $125 million to acquire unlisted Minnesota-based Rotation Medical, plus up to $85 million over the next five years if certain financial targets are hit.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : October 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017
    Capital Cube2 months ago

    Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Smith & Nephew Plc with the following peers – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Edwards Lifesciences Corporation, Boston Scientific Corporation, Stryker Corporation, C. R. Bard, Inc., Exactech, Inc., Orthofix International NV and CONMED Corporation (ZBH-US, JNJ-US, EW-US, BSX-US, SYK-US, BCR-US, EXAC-US, OFIX-US and ... Read more (Read more...)

  • TheStreet.com2 months ago

    Smith & Nephew Surges to Record High on Reports of Elliott Stake

    Paul Singer's Elliott is said to have started building a stake in the maker of artificial hips and knees, sending shares higher.

  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark
    Investor's Business Daily2 months ago

    Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Why MannKind, Nutanix, and Smith & Nephew Jumped Today
    Motley Fool2 months ago

    Why MannKind, Nutanix, and Smith & Nephew Jumped Today

    On a sunny day for the market, these stocks gained ground. Find out why.

  • Reuters2 months ago

    Elliott Management builds stake in Smith & Nephew - Bloomberg

    It is unclear how much stake the activist investor owns or what it plans to push for at the company, according to the Bloomberg report. "We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed," Smith & Nephew said in an emailed statement. Elliott declined to comment.

  • Elliott's Deal Magic Is Put to the Test
    Bloomberg2 months ago

    Elliott's Deal Magic Is Put to the Test

    The hedge fund has taken a stake in Smith & Nephew, which year after year has disappointed M&A speculators.

  • Singer's Elliott Builds a Stake in Smith & Nephew
    Bloomberg2 months ago

    Singer's Elliott Builds a Stake in Smith & Nephew

    Billionaire Paul Singer’s hedge fund Elliott Management Corp. has built a stake in Smith & Nephew Plc, the maker of artificial hips and knees, according to people familiar with the matter.

  • Stocks Showing Improved Relative Strength: Smith & Nephew
    Investor's Business Daily2 months ago

    Stocks Showing Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks
    Zacks2 months ago

    Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

    Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : October 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)